These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6775530)

  • 1. Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.
    Choy FY; Davidson RG
    Am J Hum Genet; 1980 Sep; 32(5):670-80. PubMed ID: 6775530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY; Bouillon L; Laurin CA
    Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophoresis of glucocerebrosidase from normal and Gaucher disease fibroblasts.
    Dale GL; Gudas J; Woloszyn W; Beutler E
    Am J Hum Genet; 1979 Jul; 31(4):518-21. PubMed ID: 484554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A; Salvayre R; Samadi M; Douste-Blazy L
    Enzyme; 1987; 37(4):208-17. PubMed ID: 3038513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel chromogenic substrate for assaying glucocerebrosidase activity.
    Gal AE; Pentchev PG; Fash FJ
    Proc Soc Exp Biol Med; 1976 Nov; 153(2):363-6. PubMed ID: 995968
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.
    Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J
    Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a fluorescent derivative of glucosyl ceramide for the sensitive determination of glucocerebrosidase activity.
    Dinur T; Grabowski GA; Desnick RJ; Gatt S
    Anal Biochem; 1984 Jan; 136(1):223-34. PubMed ID: 6424502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebroside-beta-glucosidase activity in Gaucher brain.
    Svennerholm L; Månsson JE; Rosengren B
    Clin Genet; 1986 Aug; 30(2):131-5. PubMed ID: 3757304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.
    Choy FY; Woo M; Potier M
    Biochim Biophys Acta; 1986 Mar; 870(1):76-81. PubMed ID: 3947649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
    Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of adult Gaucher disease: use of a new chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside, in cultured skin fibroblasts.
    Johnson WG; Gal AE; Miranda AF; Pentchev PG
    Clin Chim Acta; 1980 Mar; 102(1):91-7. PubMed ID: 7389109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.
    Barns RJ; Clague AE
    Clin Chim Acta; 1982 Mar; 120(1):57-63. PubMed ID: 7067140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease.
    Håkansson G; Dreborg S; Lindsten J; Svennerholm L
    Clin Genet; 1980 Oct; 18(4):268-73. PubMed ID: 6777099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage.
    Wenger DA; Roth S; Kudoh T; Grover WD; Tucker SH; Kaye EM; Ullman MD
    Pediatr Res; 1983 May; 17(5):344-8. PubMed ID: 6856396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.